These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 33054823

  • 1. Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
    Elefante E, Tani C, Stagnaro C, Signorini V, Parma A, Carli L, Zucchi D, Ferro F, Mosca M.
    Arthritis Res Ther; 2020 Oct 14; 22(1):241. PubMed ID: 33054823
    [Abstract] [Full Text] [Related]

  • 2. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
    Elefante E, Tani C, Stagnaro C, Ferro F, Parma A, Carli L, Signorini V, Zucchi D, Peta U, Santoni A, Raffaelli L, Mosca M.
    RMD Open; 2020 Feb 14; 6(1):. PubMed ID: 32075876
    [Abstract] [Full Text] [Related]

  • 3. Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life.
    Elefante E, Tani C, Stagnaro C, Signorini V, Lenzi B, Zucchi D, Trentin F, Carli L, Ferro F, Mosca M.
    Front Med (Lausanne); 2022 Feb 14; 9():859840. PubMed ID: 35425779
    [Abstract] [Full Text] [Related]

  • 4. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 14; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 5. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
    Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A, Asia-Pacific Lupus Collaboration.
    Lancet Rheumatol; 2023 Oct 14; 5(10):e584-e593. PubMed ID: 38251484
    [Abstract] [Full Text] [Related]

  • 6. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI, Rabie M, Hassan RA.
    Clin Rheumatol; 2021 Nov 14; 40(11):4553-4558. PubMed ID: 34142298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
    Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration.
    Ann Rheum Dis; 2016 Sep 14; 75(9):1615-21. PubMed ID: 26458737
    [Abstract] [Full Text] [Related]

  • 10. Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
    Emamikia S, Oon S, Gomez A, Lindblom J, Borg A, Enman Y, Morand E, Grannas D, van Vollenhoven RF, Nikpour M, Parodis I.
    Rheumatology (Oxford); 2022 Nov 28; 61(12):4752-4762. PubMed ID: 35302581
    [Abstract] [Full Text] [Related]

  • 11. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study.
    Golder V, Kandane-Rathnayake R, Li N, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Wu YJ, Navarra SV, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Goldblatt F, Oon S, O'Neill S, Ng K, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Lau CS, Hoi A, Nikpour M, Morand EF, Asia Pacific Lupus Collaboration.
    Lancet Rheumatol; 2024 Aug 28; 6(8):e528-e536. PubMed ID: 38876129
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
    Na Nakorn K, Piyaphanee N, Sukharomana M, Pinpatanapong R, Charuvanij S.
    Clin Rheumatol; 2023 Jun 28; 42(6):1655-1664. PubMed ID: 36780064
    [Abstract] [Full Text] [Related]

  • 13. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K, Schmidt W, Leszczyński P.
    Eur Rev Med Pharmacol Sci; 2023 Feb 28; 27(3):949-959. PubMed ID: 36808341
    [Abstract] [Full Text] [Related]

  • 14. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort.
    Altabás-González I, Rúa-Figueroa I, Rubiño F, Mouriño Rodríguez C, Hernández-Rodríguez I, Menor Almagro R, Uriarte Isacelaya E, Tomero Muriel E, Salman-Monte TC, Carrión-Barberà I, Galindo M, Rodríguez Almaraz EM, Jiménez N, Inês L, Pego-Reigosa JM.
    Rheumatology (Oxford); 2023 Mar 01; 62(3):1162-1169. PubMed ID: 35961050
    [Abstract] [Full Text] [Related]

  • 15. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA, Canti V, Moiola L, Magnoni M, Rovere-Querini P, Coletto LA, Dagna L, Manfredi AA, Bozzolo EP.
    Int J Rheum Dis; 2019 Sep 01; 22(9):1752-1761. PubMed ID: 31379114
    [Abstract] [Full Text] [Related]

  • 16. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.
    Golder V, Kandane-Rathnayake R, Hoi AY, Huq M, Louthrenoo W, An Y, Li ZG, Luo SF, Sockalingam S, Lau CS, Mok MY, Lateef A, Franklyn K, Morton S, Navarra ST, Zamora L, Wu YJ, Hamijoyo L, Chan M, O'Neill S, Goldblatt F, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration.
    Arthritis Res Ther; 2017 Mar 20; 19(1):62. PubMed ID: 28320433
    [Abstract] [Full Text] [Related]

  • 17. Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up.
    Parodis I, Stephens T, Dominicus A, Eek D, Sjöwall C.
    Rheumatology (Oxford); 2024 Feb 24. PubMed ID: 38402496
    [Abstract] [Full Text] [Related]

  • 18. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
    Piga M, Floris A, Cappellazzo G, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Res Ther; 2017 Nov 10; 19(1):247. PubMed ID: 29126432
    [Abstract] [Full Text] [Related]

  • 19. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
    Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Lofland J, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA.
    Lupus Sci Med; 2022 Feb 10; 9(1):. PubMed ID: 35193948
    [Abstract] [Full Text] [Related]

  • 20. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
    Kikuchi J, Hanaoka H, Saito S, Oshige T, Hiramoto K, Kaneko Y, Takeuchi T.
    Rheumatology (Oxford); 2022 Aug 30; 61(9):3777-3791. PubMed ID: 35015824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.